Credit Suisse’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-6,893,749
Closed -$685M 4483
2019
Q3
$685M Sell
6,893,749
-353,189
-5% -$33.6M 0.58% 20
2019
Q2
$670M Buy
7,246,938
+3,091,495
+74% +$294M 0.59% 17
2019
Q1
$392M Buy
4,155,443
+2,133,985
+106% +$187M 0.36% 38
2018
Q4
$130M Buy
2,021,458
+271,079
+15% +$20M 0.13% 140
2018
Q3
$157M Buy
1,750,379
+144,788
+9% +$12.8M 0.14% 127
2018
Q2
$128M Sell
1,605,591
-543,455
-25% -$45.1M 0.13% 142
2018
Q1
$192M Sell
2,149,046
-81,649
-4% -$7.84M 0.18% 99
2017
Q4
$233M Buy
2,230,695
+297,148
+15% +$33.5M 0.21% 87
2017
Q3
$282M Sell
1,933,547
-165,567
-8% -$22.6M 0.27% 61
2017
Q2
$273M Sell
2,099,114
-211,438
-9% -$25.9M 0.27% 67
2017
Q1
$288M Buy
2,310,552
+288,753
+14% +$34.6M 0.26% 66
2016
Q4
$234M Sell
2,021,799
-691,710
-25% -$77M 0.23% 77
2016
Q3
$284M Buy
2,713,509
+305,737
+13% +$33.1M 0.27% 60
2016
Q2
$237M Sell
2,407,772
-262,299
-10% -$27.1M 0.26% 66
2016
Q1
$267M Sell
2,670,071
-254,840
-9% -$26.2M 0.32% 57
2015
Q4
$350M Sell
2,924,911
-171,950
-6% -$19.9M 0.4% 37
2015
Q3
$335M Sell
3,096,861
-232,123
-7% -$28.8M 0.4% 38
2015
Q2
$385M Buy
3,328,984
+402,894
+14% +$46.1M 0.38% 42
2015
Q1
$337M Sell
2,926,090
-266,873
-8% -$31.9M 0.34% 49
2014
Q4
$357M Sell
3,192,963
-285,054
-8% -$30.1M 0.32% 54
2014
Q3
$330M Buy
3,478,017
+623,090
+22% +$56.2M 0.27% 68
2014
Q2
$245M Sell
2,854,927
-71,647
-2% -$5.45M 0.2% 89
2014
Q1
$204M Sell
2,926,574
-230,058
-7% -$18.2M 0.2% 92
2013
Q4
$267M Buy
3,156,632
+459,134
+17% +$36.3M 0.24% 70
2013
Q3
$208M Sell
2,697,498
-431,032
-14% -$30.2M 0.21% 81
2013
Q2
$183M Buy
+3,128,530
New +$188M 0.18% 89

Other funds holding CELG

Credit Suisse's CELG Position: Q4 2019 in Review

Credit Suisse sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 6,893,749 shares — an estimated $685M sold.

Credit Suisse first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $685M in Q3 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Credit Suisse reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Credit Suisse sold 6,893,749 Celgene Corp shares in Q4 2019, an estimated $685M.
  • Credit Suisse first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Credit Suisse's Celgene Corp position peaked at $685M in Q3 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.